Market Scenario
Menopause is termed as the stage of the end of the fertile phase in women which generally occurs at the age of 40 in almost 85% of women. Menopause results in reduced estrogen production and increased gonadotropin, resulting in the cessation of their menstrual cycle and menstrual flow. These physiological changes result in vasomotor symptoms. Vasomotor symptoms are transition between two phases which are peri-menopause and menopause. The major symptoms associated with menopause are as follows
Hot flashes – Hot flash is the most frequent symptoms of menopause which causes feeling of intensity of heat and excessive sweating.
Formication – Formication in an abnormal skin sensation, itchiness, tingling or burning on the skin and other.
Migraine – Migraine is intense headache which can last from few hours up to many days generally affecting one side of the head. Migraine is a direct effect of hormonal fluctuations of menstrual cycle.
Psychological symptoms associated with menopause are fatigue, anxiety, irritability, mood swings, insomnia etc. Other symptoms of menopause are dysfunctional uterine bleeding, disturbed sleep pattern and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4579
The market drivers for global menopause treatment market are rise in population, increasing awareness regarding women health, development of healthcare and gynaecology centres, and development in drugs especially the advancements in hormonal drugs etc. The market restraints are the complications of drug treatment such as osteoporosis, bleeding, high cost of treatment, etc.
The global menopause treatment market is expected to reach USD 3.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.2 % during the forecast period 2017-2023.
Key Players in the Global Menopause treatment Market
Some of the key players profiled in the report are Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Allergan plc, Emcure Pharmaceuticals Ltd., Eli Lilly and Company, Cipla Inc., Teva Pharmaceutical Industries Ltd., and others.
Segments
The global menopause treatment market has been segmented on the basis of hormonal treatment, non-hormonal treatment and end user.
Based on the hormonal treatment, the market has been segmented as estrogen, progesterone, combination of the two and other.
Based on the non-hormonal treatment, the market has been segmented as anti-depressants, anti-anxiety, anti-migraine and others.
Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.
Regional Analysis
The Americas account for a significant market share owing to high expenditure on the healthcare. Additionally, the fastest uptake of new products in the US drives the menopause treatment market. Furthermore, concentration of the major healthcare companies in the developed countries of this region coupled with large insurance penetration is adding fuel to the market growth. Moreover, the US expend high amount on its healthcare, which accounts for 16% of total GDP, that also increases the sale in menopause treatment market.
Europe is the second largest market in the world due to high income and strong healthcare penetration. The European market growth is led by countries such as Germany and France. The UK is expected to be the fastest growing market over the assessment period. The strong pharmaceutical industry in Germany is a strong driver behind the dominance of this country in Europe.
Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare insurance in the Asia Pacific region is expected to drive the future menopause treatment market in the region.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a moderate growth owing to poor economic and political conditions, and poor healthcare development.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4579
Detailed Table of Contents:
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
…Continued
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4579
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com